Frequency diverse array (FDA) produces an angle range dependent and time-varying transmit beampattern due to the small frequency increment across its array elements, which provides potential applications for secure communications and radio frequency stealth. In this article, we study the low probability of intercept (LPI) properties of FDA transmitted signals under typical passive reconnaissance techniques. First, the passive reconnaissance property of direction-of-arrival estimation for FDA transmitted signals under phase interferometry measurement is evaluated, together with the corresponding Cramér–Rao bound analysis. Second, the passive reconnaissance property of time difference of arrival and frequency difference of arrival estimation for FDA transmitted signals are also evaluated for moving platforms. Both theoretical analysis and numerical results demonstrate that FDA transmitted signal indeed achieves significantly better LPI performance than phased-array transmitted signals, which is particularly useful for military applications.
Existing studies on frequency diverse array (FDA) radar sensing systems have primarily focused on radio-frequency (RF) stealth characteristics with limited attention to the balance between RF stealth and active detection performance. To address this issue, this paper proposes a joint transmit–receive weight optimization scheme for FDA radar systems to achieve an effective balance between active detection and RF stealth. The resulting optimization problem is non-convex, and a block coordinate descent (BCD)-based alternating optimization method with a carefully designed initialization strategy is developed to solve it efficiently. Simulation results demonstrate that the proposed method achieves improved RF stealth performance while maintaining comparable active detection capability, compared with conventional FDA radar and representative existing optimization-based benchmark methods. These results demonstrate the effectiveness of the proposed method for balancing active detection and RF stealth performance in FDA radar sensing systems.